semaglutide schizophrenia In a randomized clinical trial published in JAMA Psychiatry, a #GLP1 receptor agonist was assessed in patients with #Schizophrenia who were obese and had prediabetes. Over 30 weeks, Semaglutide Safely Improves Metabolic Health

Kahler, W., Kuklinski, B., Ruhlmann, C., and Plotz, C

The study showed significant increases in intracellular glutathione levels after just 2 weeks of use, as well as demonstrating its ability to support healthy NK cell function and oxidative stress levels.* Are there any risks to taking liposomal glutathione

Patients often share experiences of decreased appetite, quicker satiety during meals, and higher energy levels for activities

No additional updates are warranted to product information for any GLP-1 drug, the agency saidboth Wegovy and Ozempic already indicate on their safety labels the drugs have caused thyroid tumors in studies with rodents, but note it is unknown whether the drugs can cause thyroid tumors or thyroid cancer

Im fortunate that I live in a country with a national health system and can purchase the drug for a subsidised rate (AU$42.50 per month, ~US$30)

To counteract these elevated ROS levels, cancer cells often upregulate ROS-scavenging genes, making them attractive targets for anti-cancer therapies